Movement Alert｜Insilico Medicine Falls 5.69% in Regular Trading, Massive Lock-up Expiry Approaching Amid Broad Sector Weakness

Market Focus06-08

On June 8, Insilico Medicine fell 5.69% in regular trading, trading at 35.68 HKD/share, with trading volume of approximately 54.76 million HKD.

On the news front, the company's cornerstone investors and employee restricted shares lock-up period is set to expire on June 29, with approximately 453 million shares (representing 81.25% of total share capital) facing potential unlocking. Market concerns over imminent selling pressure have intensified offloading behavior. Additionally, the company previously clarified it has no definite plans for a secondary listing in Abu Dhabi, dashing market expectations for expanded international financing channels.

Within the Life Sciences Tools & Services sector, broad weakness further amplified the decline. WuXi Biologics fell 5.38%, WuXi XDC dropped 4.61%, GenScript Biotech declined 4.26%, XtalPi lost 3.2%, and WuXi AppTec fell 2.89%. The stock has now accumulated a decline of nearly 40% over the past month, with sustained downward momentum.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1124659105?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-08 10:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1124659105","market":"us","top_or_hot":-1,"title":"Movement Alert｜Insilico Medicine Falls 5.69% in Regular Trading, Massive Lock-up Expiry Approaching Amid Broad Sector Weakness","media":"Market Focus","content":"<p><p>On June 8, Insilico Medicine fell 5.69% in regular trading, trading at 35.68 HKD/share, with trading volume of approximately 54.76 million HKD.</p><p>On the news front, the company's cornerstone investors and employee restricted shares lock-up period is set to expire on June 29, with approximately 453 million shares (representing 81.25% of total share capital) facing potential unlocking. Market concerns over imminent selling pressure have intensified offloading behavior. Additionally, the company previously clarified it has no definite plans for a secondary listing in Abu Dhabi, dashing market expectations for expanded international financing channels.</p><p>Within the Life Sciences Tools & Services sector, broad weakness further amplified the decline. WuXi Biologics fell 5.38%, WuXi XDC dropped 4.61%, GenScript Biotech declined 4.26%, XtalPi lost 3.2%, and WuXi AppTec fell 2.89%. The stock has now accumulated a decline of nearly 40% over the past month, with sustained downward momentum.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Insilico Medicine Falls 5.69% in Regular Trading, Massive Lock-up Expiry Approaching Amid Broad Sector Weakness</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Insilico Medicine Falls 5.69% in Regular Trading, Massive Lock-up Expiry Approaching Amid Broad Sector Weakness\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-08 10:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 8, Insilico Medicine fell 5.69% in regular trading, trading at 35.68 HKD/share, with trading volume of approximately 54.76 million HKD.</p><p>On the news front, the company's cornerstone investors and employee restricted shares lock-up period is set to expire on June 29, with approximately 453 million shares (representing 81.25% of total share capital) facing potential unlocking. Market concerns over imminent selling pressure have intensified offloading behavior. Additionally, the company previously clarified it has no definite plans for a secondary listing in Abu Dhabi, dashing market expectations for expanded international financing channels.</p><p>Within the Life Sciences Tools & Services sector, broad weakness further amplified the decline. WuXi Biologics fell 5.38%, WuXi XDC dropped 4.61%, GenScript Biotech declined 4.26%, XtalPi lost 3.2%, and WuXi AppTec fell 2.89%. The stock has now accumulated a decline of nearly 40% over the past month, with sustained downward momentum.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03696","symbol_name":"英矽智能","start_time":0,"source_url":"","article_id":"1124659105","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1124659105","pubTimestamp":1780885412,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 8, Insilico Medicine fell 5.69% in regular trading, trading at 35.68 HKD/share, with trading volume of approximately 54.76 million HKD.On the news front, the company's cornerstone investors...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03696":"英矽智能"},"translate_title":"动向提示|英矽智能常规交易下跌5.69%，在广泛行业疲软的情况下，大规模禁售期即将到期","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03696":1},"content_text":"On June 8, Insilico Medicine fell 5.69% in regular trading, trading at 35.68 HKD/share, with trading volume of approximately 54.76 million HKD.On the news front, the company's cornerstone investors and employee restricted shares lock-up period is set to expire on June 29, with approximately 453 million shares (representing 81.25% of total share capital) facing potential unlocking. Market concerns over imminent selling pressure have intensified offloading behavior. Additionally, the company previously clarified it has no definite plans for a secondary listing in Abu Dhabi, dashing market expectations for expanded international financing channels.Within the Life Sciences Tools & Services sector, broad weakness further amplified the decline. WuXi Biologics fell 5.38%, WuXi XDC dropped 4.61%, GenScript Biotech declined 4.26%, XtalPi lost 3.2%, and WuXi AppTec fell 2.89%. The stock has now accumulated a decline of nearly 40% over the past month, with sustained downward momentum.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1124659105","isCrawlerRequest":true}